Marvell Technology Inc. has acquired plasmonics-based silicon photonic device maker Polariton Technologies. The move will strengthen Marvell’s optical technology portfolio, adding advanced modulation ...

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, ...

Marvell Technology has announced the acquisition of Polariton Technologies, a developer of high-speed, low-power plasmonics-based silicon photonics devices, strengthening Marvell' ...

Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...

Researchers reported favorable safety and tolerability for CS1 after 12 months of treatment in patients with pulmonary arterial hypertension.

Grifols (NASDAQ:GRFS) is one of the overlooked growth stocks to buy now. On March 17, Grifols unveiled proof-of-concept data ...

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...

John Steinbach was shocked to receive a $281 electricity bill in January 2026—a huge spike from the roughly $100 he’d paid the previous month. “It’s just so far beyond any bill that I’ve ever had,” he ...

New data confirm Revi’s unmatched durability, 95% patient satisfaction, and excellent safety over three years, setting a new standard in Implantable Tibial Neuromodulation SALT LAKE CITY--(BUSINESS ...

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on ...